Experience

Merus – $172.5 Million Follow-on Offering

August 14, 2023

Cooley advised the underwriters in Merus’ $172.5 million follow-on offering. Jefferies, BofA Securities, Guggenheim Securities and William Blair acted as joint book-running managers for the offering. Merus is a clinical-stage oncology company developing innovative, full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics. Partners Denny Won, Courtney Thorne and Div Gupta led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Courtney Thorne
Partner, Boston
Div Gupta
Partner, New York
Evan Leitner
Associate, New York
David D. Kim
Associate, San Francisco
Charles York
Associate, New York
Kindall G. Jackson
Associate, Washington DC
Peter A. Haddad
Associate, San Diego

Related Practices & Industries

Turnstone Biologics Announces Upsized $80 Million IPO

July 26, 2023

Cooley advised Turnstone Biologics, a clinical-stage biotechnology company, on its upsized $80 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Ryan Sansom
Partner, Boston
Lila Hope
Partner, Palo Alto
Alexa M. Smith (Ekman)
Associate, San Diego
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Julianne Orr
Associate, San Francisco
Anitha Anne
Associate, San Francisco
Cathy Rude
Senior Paralegal, Boston
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Tony P. Guan
Associate, Los Angeles Santa Monica
Elizabeth Anne Wright
Partner, Brussels
Jessica Koffel
Associate, Brussels
Aaron Pomeroy
Partner, Colorado
Rick Jantz
Associate, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Francis Wheeler
Partner, Colorado

Related Practices & Industries

Immunology Company argenx Announces $1.27 Billion Global Offering

July 26, 2023

Cooley advised J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities and TD Cowen, representatives of the several underwriters, in the $1.27 billion follow-on offering by argenx SE, a global immunology company.

Read more

Related contacts

Richard Segal
Partner, New York
Div Gupta
Partner, New York
Darah Protas
Associate, Washington DC
Charles York
Associate, New York
Katie Lapidus
Associate, Washington DC
Carley Cruea
Associate, Washington DC
Bill Christiansen
Partner, Seattle
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Dr. Tian Yong Zheng
Patent Agent, Seattle

Related Practices & Industries

Apogee Therapeutics Announces Upsized $345.1 Million IPO

July 18, 2023

Cooley advised the underwriters in the upsized $345.1 million initial public offering of Apogee Therapeutics, a biotechnology company.

Read more

Related contacts

Charlie Kim
Partner, San Diego
Div Gupta
Partner, New York
Kristin VanderPas
Partner, San Francisco
Madhuri Roy
Partner, Palo Alto
Stephanie Gentile
Partner, New York
Geoffrey Spolyar
Partner, Boston
Phil Mitchell
Partner, New York
Francis Wheeler
Partner, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Randy Sabett
Special Counsel, Washington DC
Natasha Leskovsek
Of Counsel, Washington DC
Rebecca Ross
Special Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Madison (JJ) Meng
Associate, San Francisco
Megan Drill
Associate, San Diego
Alessandra Murata
Partner, Palo Alto
Darah Protas
Associate, Washington DC
Mike Lam
Associate, Los Angeles Santa Monica
David Dalton
Associate, Los Angeles Santa Monica
Peter A. Haddad
Associate, San Diego

Related Practices & Industries

NewAmsterdam Pharma – $181.6 Million Follow-on Offering

June 6, 2023

Cooley advised the underwriters in NewAmsterdam Pharma’s $181.6 million follow-on offering. NewAmsterdam is a clinical-stage biopharmaceutical company with a mission to improve care of patients with metabolic diseases where currently approved therapies have not been sufficiently successful or well tolerated. Lawyers Eric Blanchard, Div Gupta, Jean Park, Minkyu Park, Charles York, and Katie Lapidus led the Cooley team.

Related contacts

Eric Blanchard
Partner, New York
Div Gupta
Partner, New York
Jean Park
Partner, New York
Minkyu Park
Associate, New York
Charles York
Associate, New York
Katie Lapidus
Associate, Washington DC

Related Practices & Industries

View more

Rankings & accolades

Chambers USA: Life Sciences: Corporate/Commercial – Nationwide (2022 – 2023)

Chambers USA: Capital Markets: Debt & Equity: Eastern United States – Nationwide (2020 – 2023)

Legal 500: Key Lawyer - Capital Markets: Equity Offerings and Healthcare: Life Sciences (2020 – 2021)

Law 360 Rising Star (2015)

Who's Who Legal: Life Sciences (2018)

highly regarded for his experience assisting life sciences companies on IPOs and other capital markets matters

Divakar is excellent in supporting our company.

Chambers USA: Life Sciences: Corporate/Commercial 

Nationwide (2022)